Company intelligence / Profile preview
Jenrin Discovery
Chadds Ford, Pennsylvania, United Statesjenrindiscovery.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Developing small molecule drugs that selectively target peripheral tissues without affecting the brain, focusing on treatments for chronic diseases
- Therapeutic areas
- GastroenterologyEndocrinologyMetabolic DisordersImmunology
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Corbus (received over 600 endocannabinoid-targeting compounds from Jenrin)
Beyond the preview
Go deeper on Jenrin Discovery.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jenrin Discovery.